JO
ELOX

John Overdeck’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

John Overdeck’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-577
Closed -$13K – 3116
2022
Q1 		$13K Sell
577
-2,366
-80% -$46.6K ﹤0.01% 2536
2021
Q4 		$83K Sell
2,943
-4,929
-63% -$215K ﹤0.01% 4089
2021
Q3 		$513K Buy
7,872
+5,209
+196% +$321K ﹤0.01% 3239
2021
Q2 		$212K Buy
+2,663
New +$222K ﹤0.01% 3754
2019
Q4 		– Sell
-650
Closed -$118K – 4085
2019
Q3 		$118K Buy
+650
New +$185K ﹤0.01% 3285
2018
Q3 		– Sell
-527
Closed -$360K – 3722
2018
Q2 		$360K Buy
+527
New +$342K ﹤0.01% 2829

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

John Overdeck's ELOX Position: Q2 2022 in Review

John Overdeck sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2022, closing a stake of 577 shares — an estimated $13K sold.

John Overdeck first reported a position in ELOX in Q2 2018 and held it in 6 quarters. The position peaked at $513K in Q3 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

  • John Overdeck reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • John Overdeck sold 577 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $13K.
  • John Overdeck first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • John Overdeck's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $513K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.